Thus, we examined the therapeutic activity of an anti‐PD‐L1 Ab in vitro and in vivo, either alone or in combination with FU/Oxa, in chemoresistant CRC cells carrying enforced SA14 expression. The gene discussed is CD274; the disease is colorectal carcinoma.